Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Assets Average (2017 - 2025)

Acro Biomedical has reported Assets Average over the past 9 years, most recently at $9210.5 for Q4 2025.

  • Quarterly results put Assets Average at $9210.5 for Q4 2025, down 73.93% from a year ago — trailing twelve months through Dec 2025 was $9210.5 (down 73.93% YoY), and the annual figure for FY2025 was $23036.0, down 49.05%.
  • Assets Average for Q4 2025 was $9210.5 at Acro Biomedical, down from $28800.0 in the prior quarter.
  • Over the last five years, Assets Average for ACBM hit a ceiling of $968463.5 in Q1 2021 and a floor of $9210.5 in Q4 2025.
  • Median Assets Average over the past 5 years was $438565.0 (2023), compared with a mean of $389417.4.
  • Biggest five-year swings in Assets Average: dropped 0.75% in 2021 and later plummeted 94.18% in 2023.
  • Acro Biomedical's Assets Average stood at $695452.5 in 2021, then dropped by 4.3% to $665567.0 in 2022, then plummeted by 94.18% to $38743.0 in 2023, then fell by 8.82% to $35325.0 in 2024, then plummeted by 73.93% to $9210.5 in 2025.
  • The last three reported values for Assets Average were $9210.5 (Q4 2025), $28800.0 (Q3 2025), and $39226.0 (Q2 2025) per Business Quant data.